Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/203851
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | E‐cadherin expression is associated with somatostatin analogue response in acromegaly |
Autor: | Venegas Moreno, Eva CSIC; Flores-Martínez, Alvaro; Dios Fuentes, Elena CSIC; Vázquez-Borrego, Mari C.; Ibáñez-Costa, Alejandro; Madrazo Atutxa, Ainara CSIC; Japón, Miguel A. CSIC ORCID; Castaño, Justo P.; Luque, Raúl M.; Cano González, David A. CSIC ORCID; Soto-Moreno, Alfonso CSIC ORCID | Palabras clave: | Acromegaly E‐cadherin Pituitary tumour Somatostatin analogues Somatostatin receptor |
Fecha de publicación: | may-2019 | Editor: | Wiley-Blackwell | Citación: | Journal of Cellular and Molecular Medicine 23(5): 3088-3096 (2019) | Resumen: | Acromegaly is a rare disease resulting from hypersecretion of growth hormone (GH) and insulin‐like growth factor 1 (IGF1) typically caused by pituitary adenomas, which is associated with increased mortality and morbidity. Somatostatin analogues (SSAs) represent the primary medical therapy for acromegaly and are currently used as first‐line treatment or as second‐line therapy after unsuccessful pituitary surgery. However, a considerable proportion of patients do not adequately respond to SSAs treatment, and therefore, there is an urgent need to identify biomarkers predictors of response to SSAs. The aim of this study was to examine E‐cadherin expression by immunohistochemistry in fifty‐five GH‐producing pituitary tumours and determine the potential association with response to SSAs as well as other clinical and histopathological features. Acromegaly patients with tumours expressing low E‐cadherin levels exhibit a worse response to SSAs. E‐cadherin levels are associated with GH‐producing tumour histological subtypes. Our results indicate that the immunohistochemical detection of E‐cadherin might be useful in categorizing acromegaly patients based on the response to SSAs. | Versión del editor: | https://doi.org/10.1111/jcmm.13851 | URI: | http://hdl.handle.net/10261/203851 | DOI: | 10.1111/jcmm.13851 | ISSN: | 1582-1838 | E-ISSN: | 1582-4934 |
Aparece en las colecciones: | (IBIS) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
E‐cadherin_expression.pdf | 577,55 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
16
checked on 16-abr-2024
SCOPUSTM
Citations
31
checked on 17-abr-2024
WEB OF SCIENCETM
Citations
25
checked on 29-feb-2024
Page view(s)
206
checked on 19-abr-2024
Download(s)
118
checked on 19-abr-2024